This is a preprint.
Timing of antiviral treatment initiation is critical to reduce SARS-CoV-2 viral load
- PMID: 32511641
- PMCID: PMC7276997
- DOI: 10.1101/2020.04.04.20047886
Timing of antiviral treatment initiation is critical to reduce SARS-CoV-2 viral load
Update in
-
Timing of Antiviral Treatment Initiation is Critical to Reduce SARS-CoV-2 Viral Load.CPT Pharmacometrics Syst Pharmacol. 2020 Sep;9(9):509-514. doi: 10.1002/psp4.12543. Epub 2020 Aug 7. CPT Pharmacometrics Syst Pharmacol. 2020. PMID: 32558354 Free PMC article.
Abstract
We modeled the viral dynamics of 13 untreated patients infected with SARS-CoV-2 to infer viral growth parameters and predict the effects of antiviral treatments. In order to reduce peak viral load by more than 2 logs, drug efficacy needs to be greater than 80% if treatment is administered after symptom onset; an efficacy of 50% could be sufficient if treatment is initiated before symptom onset. Given their pharmacokinetic/pharmacodynamic properties, current investigated drugs may be in a range of 20-70% efficacy. They may help control virus if administered very early, but may not have a major effect in severe patients.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous